000 03835nam a22004571i 4500
999 _c119116
_d119116
_x1
001 119116
003 ES-MaUEC
005 20230207040634.0
006 a|||| o|||| 00| 0
007 cr nn nnnaamaa
008 200304s2020 si | o |||| 0|eng d
020 _a9789811520174
024 7 _a10.1007/978-981-15-2017-4
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
041 0 _aeng
050 4 _aRC280.D5
_b2020 EB
245 0 0 _aTheranostics Approaches to Gastric and Colon Cancer
_cedited by Ganji Seeta Rama Raju, L.V.K.S. Bhaskar
250 _aFirst edition 2020
264 1 _aSingapore
_bSpringer International Publishing
_c2020
300 _a1 recurso en línea (XIII, 250 páginas)
_b26 ilustraciones, 17 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
490 0 _aDiagnostics and Therapeutic Advances in GI Malignancies
_x2662-2688
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _aChapter 1. Therapeutic role of Phytochemicals in Colorectal cancer -- Chapter 2. Adiponectin Signaling In Colorectal Cancer -- Chapter 3. Role of Matrix Metalloproteinases in Colorectal Cancer -- Chapter 4. The Role of Hypoxia-Inducible Factor 1- Alpha in Colorectal Cancer -- Chapter 5. Mechanisms and pathways of metabolic reprogramming of colorectal cancer -- Chapter 6. Targeting metabolic reprogramming of colorectal cancer -- Chapter 7. Understanding colorectal cancer: the basics -- Chapter 8. Molecular signaling pathways involved in gastric cancer chemoresistance -- Chapter 9. Meta-analysis reveals no significant association of EPHX1 Tyr113His and His139Arg polymorphisms with the colorectal cancer risk -- Chapter 10. Meta-analysis of genetic variants in alcohol metabolizing enzymes and their association with colorectal cancer risk -- Chapter 11. Gut microbiota as signatures in non-communicable diseases and mucosal immunity -- Chapter 12. Immunotherapy for Colon Cancer: Recent Perspectives -- Chapter 13. Nanotechnology Applications in Gastric cancer. .
520 3 _aThis book highlights the importance of understanding gastric and colon cancer metabolism in guiding diagnosis and drug discovery. It summarizes the correlation between adiponectin and matrix metalloproteinase with colorectal cancer. The book also evaluates the divergent role of hypoxia-inducible factor 1 in colorectal cancer growth and metastasis. After discussing the role of genetic polymorphisms in alcohol metabolizing enzymes and EPHX1 with the onset of colorectal cancer, it reviews the molecular mechanisms of chemoresistance in gastric cancer and novel therapeutic strategies to reverse the chemoresistance of tumors. In addition, the book explores the theranostic role of nanoparticles and therapeutic potential of phytochemicals with regard to colorectal cancer. Given its scope, the book offers a valuable guide for oncologists, academic researchers, pharmaceuticals practitioners, and students who are involved in research and treatment of cancer.
988 _aSpringer_BiomedLife_31032020
650 7 _2embne
_9174208
_aAparato digestivo
_xCáncer
650 7 _2embne
_9182269
_aColon
_xCáncer
700 1 _aRaju, Ganji Seeta Rama.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aBhaskar, L.V.K.S.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
776 0 8 _iPrinted edition:
_z9789811520167
776 0 8 _iPrinted edition:
_z9789811520181
776 0 8 _iPrinted edition:
_z9789811520198
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://dx.doi.org/10.1007/978-981-15-2017-4
942 _2lcc
_cLE
_n0
998 _b04/2020
_dz
_eb
_zSI